Seneca Therapeutics Patents – Insights & Stats (Updated 2024)

Seneca Therapeutics has a total of 31 patents globally. Of these 31 patents, more than 90% patents are active. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Seneca Therapeutics.

Seneca Therapeutics was founded in the year 2018. Seneca Therapeutics is a biotechnology company involved in development of novel cancer vaccines and oncolytic immunotherapeutics, known as Seneca Valley Virus (SVV) for treatment of cancer.

Do read about some of the most popular patents of Seneca Therapeutics which have been covered by us in this article and also you can find Seneca Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Seneca Therapeutics patent portfolio.

How many patents does Seneca Therapeutics have?

Seneca Therapeutics has a total of 31 patents globally. These patents belong to 4 unique patent families. Out of 31 patents, 28 patents are active.

How Many Patents did Seneca Therapeutics File Every Year?

Seneca Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSeneca Therapeutics Applications FiledSeneca Therapeutics Patents Granted
20232
202213
20211
202015

How many Seneca Therapeutics patents are Alive/Dead?

Worldwide Patents

Seneca Therapeutics Patents Worldwide Legal Trends

How Many Patents did Seneca Therapeutics File in Different Countries?

Seneca Therapeutics Patents Worldwide Patent

Countries in which Seneca Therapeutics Filed Patents

CountryPatents
Europe (EPO)4
South Africa4
Australia4
Brazil4
Canada4
Israel4
Japan2
United States Of America2

Where are Research Centers of Seneca Therapeutics Patents Located?

The Research Centers of Seneca Therapeutics is located in the United States of America.

List of Seneca Therapeutics Patents

Seneca Therapeutics PatentsTitle
US20220249584A1Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
US20220202884A1Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
EP4281549A1Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
EP4274593A1Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
EP3999087A4Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
EP3952896A4Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
IL304170ASeneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
IL304280AArmed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
BR112023014346A2Seneca Valley Armed Virus Oncolytic Therapy Compositions And Methods Thereof
BR112023013781A2Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
ZA202306664ASeneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
ZA202306693AArmed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
AU2022210419A1Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
AU2022205429A1Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
CA3207261A1Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
CA3207860A1Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
BR112022000928A2Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Of The Same
AU2020315800A1Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
IL289912ASecond Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
ZA202200829ASecond Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
BR112021020369A2Compositions And Methods Of Use Of Seneca Valley Virus (Svv) For Treatment Of Cancer
AU2020272054A1Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
IL287117ACompositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
ZA202107941ACompositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
CA3147640A1Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods Thereof
CA3136671A1Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer
JP2022541234A5Second-Generation Seneca Valley Virus Oncolytic Therapy: Its Composition And Methods
JP2022527412A5Compositions And Methods Of Using Seneca Valley Virus (Svv) To Treat Cancer
WO2022159508A1Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods Thereof
WO2022150769A1Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint Inhibitor
WO2020210711A1Compositions And Methods Of Using Seneca Valley Virus (Svv) For Treating Cancer

What are Seneca Therapeutics key innovation segments?

What Technologies are Covered by Seneca Therapeutics?

The chart below distributes patents filed by Seneca Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Seneca Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Seneca Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Seneca Therapeutics?

Related Articles

Yotrio Group Patents – Insights & Stats (Updated 2024)

Yotrio Group has a total of 2043 patents globally, out of which 1849 have been granted. Of these 2043 patents, more than 69% patents are active. China is where Yotrio Group has filed the maximum number of patents, followed by United Kingdom and Europe (EPO). Parallelly, China seems to be

Read More »

Ufraction8 Patents – Insights & Stats (Updated 2024)

Ufraction8 has a total of 16 patents globally, out of which 7 have been granted. Of these 16 patents, more than 87% patents are active. Parallelly, United Kingdom seems to be the main focused R&D centre and also is the origin country of Ufraction8. Ufraction8 was founded in the year

Read More »

Aizant Patents – Insights & Stats (Updated 2024)

Aizant has a total of 64 patents globally, out of which 8 have been granted. Of these 64 patents, more than 45% patents are active. India is where Aizant has filed the maximum number of patents, followed by United States of America and Canada. Parallelly, India seems to be the

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.